{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:28:08Z","timestamp":1771921688459,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Acute promyelocytic leukemia (APL) is a distinct subtype of acute myeloid leukemia (AML) with unique clinical features. Flow cytometry (FCM) immunophenotyping analysis is crucial for accurate diagnosis and prognostic stratification. This study aims to explore the association between specific immune phenotype markers in APL patients and overall survival (OS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cohort study, immunophenotypic data from 72 APL patients were analyzed by FCM. Continuous and categorical variables are presented as mean \u00b1 standard deviation and frequency (percentage), respectively. Group comparisons were performed using ANOVA and Chi-square tests. Cox proportional hazards models were used to identify prognostic factors for OS, with results expressed as hazard ratios (HRs) and 95% confidence intervals (CIs). Kaplan-Meier survival analysis was employed to assess the impact of CD56, CD2, CD34, and CD200 expression on OS. Subgroup analyses were conducted based on age, gender, white blood cell count (WBC), and disseminated intravascular coagulation (DIC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The baseline age (p = 0.513) and gender (p = 0.881) were comparable across different PML-RAR\u03b1 isoform groups. Compared to non-APL AML, APL blasts were characterized by significantly higher expression of CD33, CD13, CD9, and MPO (all p &amp;lt; 0.05), and lower expression of CD7, CD34, CD56, CD38, CD200, and HLA-DR (all p &amp;lt; 0.001). The PML-RAR\u03b1 (S-type) group showed relatively higher expression of CD34, CD2, and CD200 than the L-type group. Univariate Cox analysis revealed that expression of CD34, CD2, CD56, and CD200 were all significantly associated with poorer OS. After multivariate adjustment, CD2 (adjusted HR = 1.04, 95% CI: 1.01\u20131.07, p = 0.004) and CD200 (adjusted HR = 1.04, 95% CI: 1.01\u20131.06, p = 0.009) remained independent adverse prognostic factors. Subgroup analysis confirmed that the negative prognostic impact of CD2 and CD200 expression was consistent across different patient subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Compared with non-APL-AML patients, APL patients (PML-RAR\u03b1 (S-type) and PML-RAR\u03b1 (L-type)) exhibit unique immunophenotypic changes. The expression frequencies of CD56, CD2, CD34, and CD200 in leukemia cells are significantly correlated with the OS of APL patients, and the high expression of these indicators before treatment may be an adverse prognostic factor for APL patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcell.2026.1747649","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:15:40Z","timestamp":1768367740000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between leukemic immunophenotype and overall survival in patients with acute promyelocytic leukemia: a retrospective cohort study"],"prefix":"10.3389","volume":"14","author":[{"given":"Xuan","family":"Zha","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Affiliated Hospital of Nantong University","place":["Nantong, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fu Yang People\u2019s Hospital","place":["Fuyang, Anhui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fu Yang People\u2019s Hospital","place":["Fuyang, Anhui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoYu","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fu Yang People\u2019s Hospital","place":["Fuyang, Anhui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baolan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Affiliated Hospital of Nantong University","place":["Nantong, Jiangsu, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiguo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Fu Yang People\u2019s Hospital","place":["Fuyang, Anhui, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.3390\/cancers16223855","article-title":"Acute myeloid leukemia: diagnosis and evaluation by flow cytometry","volume":"16","author":"Ally","year":"2024","journal-title":"Cancers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1182\/blood-2016-06-721662","article-title":"The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/shem.2001.20861","article-title":"Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors","volume":"38","author":"Avvisati","year":"2001","journal-title":"Seminars Hematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/ijms26010115","article-title":"Targeting CD200 in breast cancer: opportunities and challenges in immunotherapeutic strategies","volume":"26","author":"Baek","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1093\/brain\/awaf018","article-title":"Mendelian randomization identifies proteins involved in neurodegenerative diseases","volume":"148","author":"Belbasis","year":"2025","journal-title":"Brain"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1182\/blood.v84.4.1220.bloodjournal8441220","article-title":"Prognostic value of immunophenotyping in acute myeloid leukemia. Australian leukaemia study group","volume":"84","author":"Bradstock","year":"1994","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"647209","DOI":"10.3389\/fimmu.2021.647209","article-title":"PNOC expressed by B cells in cholangiocarcinoma was survival related and LAIR2 could be a T cell exhaustion biomarker in tumor microenvironment: characterization of immune microenvironment combining single-cell and bulk sequencing technology","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3760\/cma.j.issn.0253-2727.2018.03.002","article-title":"Chinese guidelines for diagnosis and treatment of acute promyelocytic leukemia (2018)","volume":"39","year":"2018","journal-title":"Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi"},{"key":"B9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/347558a0","article-title":"The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus","volume":"347","author":"de Th\u00e9","year":"1990","journal-title":"Nature"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1080\/10428194.2021.1894651","article-title":"Early mortality and overall survival in acute promyelocytic leukemia: do real-world data match results of the clinical trials?","volume":"62","author":"Dhakal","year":"2021","journal-title":"Leukemia and Lymphoma"},{"key":"B11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/cyto.b.22085","article-title":"Acute promyelocytic leukemia: immunophenotype and differential diagnosis by flow cytometry","volume":"102","author":"Fang","year":"2022","journal-title":"Cytom. Part B, Clin. Cytom."},{"key":"B12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3390\/diagnostics15040447","article-title":"Distinct phenotypic and molecular characteristics of CD34-and CD34+ hematopoietic stem\/progenitor cell subsets in cord blood and bone marrow samples: implications for clinical applications","volume":"15","author":"Gaafar","year":"2025","journal-title":"Diagn. Basel, Switz."},{"key":"B13","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1080\/10428190310001617295","article-title":"Clinico-biological features and prognostic significance of PML\/RARalpha isoforms in adult patients with acute promyelocytic leukemia treated with all trans retinoic acid (ATRA) and chemotherapy","volume":"45","author":"Gupta","year":"2004","journal-title":"Leukemia and Lymphoma"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e002968","DOI":"10.1136\/jitc-2021-002968","article-title":"Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML","volume":"9","author":"Herbrich","year":"2021","journal-title":"J. For Immunother. Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1342671","DOI":"10.3389\/fonc.2024.1342671","article-title":"Clinical analysis of 82 cases of acute promyelocytic leukemia with PML-RAR\u03b1 short isoform in children and adults","volume":"14","author":"Huang","year":"2024","journal-title":"Front. Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1007\/s00277-023-05422-z","article-title":"Predictors of very early death in acute promyelocytic leukemia: a retrospective real-world cohort study","volume":"102","author":"Infante","year":"2023","journal-title":"Ann. Hematol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"104597","DOI":"10.1016\/j.yexmp.2020.104597","article-title":"Overexpression of CD200 and CD123 is a major influential factor in the clinical course of pediatric acute myeloid leukemia","volume":"118","author":"Kandeel","year":"2020","journal-title":"Exp. Mol. Pathology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12879-024-09176-5","article-title":"Causal effects of gut microbiome on HIV infection: a two-sample Mendelian randomization analysis","volume":"24","author":"Li","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1186\/s12885-024-13348-6","article-title":"A distinct subgroup of AML resembling the APL immunophenotype is associated with DIC","volume":"24","author":"Li","year":"2024","journal-title":"BMC Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12933-025-02790-w","article-title":"Causal association of modifiable factors with cardiometabolic multimorbidity: an exposome-wide Mendelian randomization investigation","volume":"24","author":"Li","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1309\/XC8P-9M8N-KQDT-38LB","article-title":"Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis","volume":"121","author":"Lin","year":"2004","journal-title":"Am. J. Clin. Pathology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/cancers12030624","article-title":"Acute promyelocytic leukemia: a constellation of molecular events around a single PML-RARA fusion gene","volume":"12","author":"Liquori","year":"2020","journal-title":"Cancers"},{"key":"B23","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41375-025-02530-9","article-title":"Distinct leukemogenic mechanism of acute promyelocytic leukemia based on genomic structure of PML::RAR\u03b1","volume":"39","author":"Minami","year":"2025","journal-title":"Leukemia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1200\/JCO.1999.17.1.293","article-title":"CD56 expression in acute promyelocytic leukemia: a possible indicator of poor treatment outcome?","volume":"17","author":"Murray","year":"1999","journal-title":"J. Clin. Oncol. Official J. Am. Soc. Clin. Oncol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.immuni.2022.10.002","article-title":"Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer","volume":"55","author":"Nixon","year":"2022","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1182\/blood.V118.21.3608.3608","article-title":"Clinical features and prognostic impact of CD56 expression in acute promyelocytic leukemia: long term follow up data from the Japan adult leukemia study Group(JALSG) APL97","volume":"118","author":"Ono","year":"2011","journal-title":"Blood"},{"key":"B27","first-page":"405","article-title":"The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements","volume":"84","author":"Orfao","year":"1999","journal-title":"Haematologica"},{"key":"B28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/bjh.17125","article-title":"Use of an anti-CD200-blocking antibody improves immune responses to AML in vitro and in vivo","volume":"193","author":"Rastogi","year":"2020","journal-title":"Br. J. Haematol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s43018-025-01054-6","article-title":"Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia","volume":"6","author":"Sand\u00e9n","year":"2025","journal-title":"Nat. Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","article-title":"Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the european LeukemiaNet","volume":"133","author":"Sanz","year":"2019","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e35806","DOI":"10.1002\/cncr.35806","article-title":"Therapeutic horizon of acute myeloid leukemia: success, optimism, and challenges","volume":"131","author":"Senapati","year":"2025","journal-title":"Cancer"},{"key":"B32","first-page":"446","article-title":"Analysing \u201ctear-drop\u201d prints of acute promyelocytic leukemia (APML): immunophenotypic prognostication of APML by FCM","volume":"11","author":"Siraj","year":"2021","journal-title":"Am. J. Blood Res."},{"key":"B33","first-page":"398","article-title":"Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129","volume":"95","author":"Slack","year":"2000","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41408-022-00753-y","article-title":"An effective and chemotherapy-free strategy of all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia in all risk groups (APL15 trial)","volume":"12","author":"Wang","year":"2022","journal-title":"Blood Cancer J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"421906","DOI":"10.1155\/2014\/421906","article-title":"Immunophenotypes and immune markers associated with acute promyelocytic leukemia prognosis","volume":"2014","author":"Xu","year":"2014","journal-title":"Dis. Markers"},{"key":"B36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3343\/alm.2024.0194","article-title":"Reclassification of acute myeloid leukemia according to the 2022 world health organization classification and the international consensus classification using open-source data","volume":"45","author":"Yun","year":"2025","journal-title":"Ann. Laboratory Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"105435","DOI":"10.1016\/j.archger.2024.105435","article-title":"Causal association of monocytes with chronic kidney disease and the mediation role of frailty: a study integrating large-scale two-sample Mendelian randomization and single-cell analysis","volume":"123","author":"Zhang","year":"","journal-title":"Archives Gerontology Geriatrics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00204-024-03910-3","article-title":"A transcriptome-wide association study integrating multi-omics bioinformatics and Mendelian randomization reveals the prognostic value of ADAMDEC1 in colon cancer","volume":"99","author":"Zhang","year":"","journal-title":"Archives Toxicol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1747649\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T06:53:38Z","timestamp":1771916018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1747649\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":38,"alternative-id":["10.3389\/fcell.2026.1747649"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1747649","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"article-number":"1747649"}}